Induction Healthcare Group
PLC
("Induction", the
"Company", or the "Group")
Grant of Options
London, UK - 17 July 2024:
Induction Healthcare Group PLC (AIM:
INHC), a leading digital health platform driving the
transformation of healthcare systems, announces that following the
announcement of the FY24 results and having met the criteria for
the granting of options, on 15 July 2024 it granted, in aggregate,
850,000 options to Paul Tambeau (Chief Executive Officer) and John
McIntosh (Chief Financial Officer) under the Company's Non-Tax
Advantaged Share Option Plan.
The Options have an exercise price of 0.5 pence
(equivalent to the nominal value of the Ordinary Shares) and, began
vesting on 5 July 2024. 33.33% of the Options shall vest on the 5
July 2025, following which equal portions shall vest every three
months across a twenty-four-month period.
Following this grant of Options, Induction has
2,400,000 Options in issue, representing approximately 2.56 per
cent. of the Company's issued share capital.
Enquiries
|
Induction
Christopher Samler, Chair
Paul Tambeau, Chief Executive
Officer
|
+44
(0)7712 194092
+44
(0)7983 104443
|
|
|
|
|
|
|
Singer Capital Markets (Nominated
Adviser and Broker)
|
+44 (0)20
7496 3000
|
|
|
Philip Davies
Alaina Wong
Finn Gordon
|
|
|
|
|
|
| |
About Induction
- www.inductionhealthcare.com
Induction (AIM: INHC) Induction delivers a suite of
software solutions through a single integrated platform that
transforms care delivery. Our system-wide applications help
healthcare providers and administrators to deliver care at any
stage remotely as well as face-to-face - giving the communities
they serve greater flexibility, control and ease of access.
Purpose-built for integration with leading Electronic Medical
Record (EMR) platforms, our products offer immediate stand-alone
value that becomes even greater when integrated with pre-existing
systems.
Used at scale by national and regional healthcare
systems, as well non-health government services, our applications
are relied upon by hundreds of thousands of clinicians and millions
of patients across almost every hospital in the British Isles.
Notification
and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with
them
|
1.
|
Details of the person discharging managerial responsibilities
/ person closely associated
|
|
a.
|
Name
|
1. Paul Tambeau - Chief Executive
Officer
2. John McIntosh - Chief Financial
Officer
|
|
2.
|
Reason for the notification
|
|
a.
|
Position/status
|
As above.
|
|
a.
|
Initial notification
/Amendment
|
Initial notification
|
|
3.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a.
|
Name
|
Induction Healthcare Group
PLC
|
|
b.
|
LEI
|
213800RY96GCZQW5TP19
|
|
4.
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a.
|
Description of the Financial
instrument, type of instrument
Identification code
|
Ordinary shares of 0.5 pence
each
GB00BJ0M3545
|
|
b.
|
Nature of the transaction
|
Grant of share options
|
|
c.
|
Price(s) and volume(s)
|
|
|
|
|
|
PDMR
|
Volume(s)
|
Price(s)
|
|
1. Paul
Tambeau
|
500,000
|
Nominal
Value
|
|
2. John
McIntosh
|
350,000
|
Nominal
Value
|
|
|
|
|
|
|
|
|
| |
|
|
d.
|
Aggregated information
Aggregated volume
Price
|
N/A - single
transactions
|
|
e.
|
Date of the transaction
|
15-07-24
|
|
f.
|
Place of the transaction
|
Off-Exchange
|
